BIOS Health Ltd

BIOS Health Ltd is a UK-based startup that utilizes AI-driven insights from the nervous system to develop neural digital therapies, serving as a pioneering force in precision medicines. The company's groundbreaking research aims to establish links between nerve activity and specific medical conditions, potentially revolutionizing treatments for diseases such as hypertension, diabetes, and neurological disorders like Parkinson’s and Alzheimer’s. Founded in 2015 by Cambridge University researchers, Emil Hewage and Oliver Armitage, BIOS boasts a multidisciplinary team with expertise spanning neuroscience, machine learning, software engineering, and biotechnology, positioning the company as a formidable player in the AI, Health Care, Medical Devices, Clean Energy, and Machine Learning industries. Their recent Venture Round investment on 09 January 2024 was backed by the Kern Venture Group, consolidating their position as an attractive investment opportunity for ventures capitalists seeking to support innovative solutions in the healthcare and AI sectors.